ライフサイエンスコーパス: functional dyspepsia

1 phageal squamous epithelium of patients with functional dyspepsia.

2 wel syndrome (IBS) and 23 (28.8%) had one of functional dyspepsia.

3 ion may be implicated in the pathogenesis of functional dyspepsia.

4 s, 722 (49.7%) met the Rome III criteria for functional dyspepsia.

5 antly for any of the diagnostic criteria for functional dyspepsia.

6 ts had peptic ulcer and 56 were diagnosed as functional dyspepsia.

7 prandial stomach distention in patients with functional dyspepsia.

8 ty of meal-related symptoms in patients with functional dyspepsia.

9 gastric accommodation, is also effective in functional dyspepsia.

10 c antidepressant therapy may be effective in functional dyspepsia.

11 may warrant an endoscopy, but most will have functional dyspepsia.

12 biome is another area for future research in functional dyspepsia.

13 ents with gastrointestinal reflux disease or functional dyspepsia.

14 cer and 9 sex- and age-matched patients with functional dyspepsia.

15 the diagnosis, evaluation, and treatment of functional dyspepsia.

16 inear mixed models, controlling for comorbid functional dyspepsia.

17 e, autoimmune gastritis, gastric cancer, and functional dyspepsia.

18 hich enhance gastric accommodation, to treat functional dyspepsia.

19 iologic targets for ameliorating symptoms of functional dyspepsia.

20 e and postprandial symptoms in patients with functional dyspepsia.

21 syndrome (8.3% and 11.4%, respectively) and functional dyspepsia (1.9% and 3.3%, respectively).

22 ents with IBS [4.4%], 2 of 201 patients with functional dyspepsia [1%], and 1 of 311 patients with fu

23 AP-FGD [irritable bowel syndrome = 91(4.9%), functional dyspepsia = 11 (0.6%), abdominal migraine = 3

24 exes more characteristic of diseases such as functional dyspepsia and gastroesophageal reflux disease

25 (23 women, 16 men) met Rome II criteria for functional dyspepsia and had no other diagnosis to accou

26 , particularly in subgroups of patients with functional dyspepsia and IBS.

27 fer insight into the pathogenesis of chronic functional dyspepsia and provide a potential model for f

28 h as gastroesophageal reflux disease (GERD), functional dyspepsia and, possibly, pancreatitis.

29 were classified as having IBS, 201 as having functional dyspepsia, and 311 as having functional abdom

30 omes such as irritable bowel syndrome (IBS), functional dyspepsia, and functional chest pain.

31 GERD and those of eosinophilic esophagitis, functional dyspepsia, and gastroparesis, posing a challe

32 rmed only modestly in identifying those with functional dyspepsia, and were not significantly superio

33 However, symptoms of functional dyspepsia are often worse after a meal, so st

34 eria is allowing recognition of nonulcer (or functional) dyspepsia as an entity that affects a sizabl

35 Although functional dyspepsia does not impart any increased risks

36 least $1 billion per year, and patients with functional dyspepsia experience a markedly reduced quali

37 ent study was to determine the prevalence of functional dyspepsia (FD) among patients with hepatitis

38 l disorders; irritable bowel syndrome (IBS), functional dyspepsia (FD) and chronic fatigue (CF).

39 Gastroesophageal reflux disease (GERD), functional dyspepsia (FD) and irritable bowel syndrome (

40 Symptoms suggestive of functional dyspepsia (FD) and irritable bowel syndrome (

41 Functional dyspepsia (FD) is a functional gastrointestin

42 Functional dyspepsia (FD) is a gastrointestinal disorder

43 Functional dyspepsia (FD) is associated with anxiety but

44 It has been reported that functional dyspepsia (FD) is associated with homozygous

45 pressants are frequently prescribed to treat functional dyspepsia (FD), a common disorder characteriz

46 physiologic abnormalities have been noted in functional dyspepsia (FD), their pathogenesis is poorly

47 risk for irritable bowel syndrome (IBS) and functional dyspepsia (FD).

48 r gastrointestinal and systemic symptoms, in functional dyspepsia (FD).

49 tributes to epigastric pain in patients with functional dyspepsia (FD); the etiology and cellular mec

50 tributes to epigastric pain in patients with functional dyspepsia (FD); the etiology and cellular mec

51 ccording to Rome III criteria as having IBS, functional dyspepsia, functional abdominal pain, or abdo

52 Symptoms of functional dyspepsia, including epigastric pain, early s

53 Patients with peptic ulcer or functional dyspepsia infected by H. pylori were randomiz

54 Functional dyspepsia is a heterogeneous disorder involvi

55 Functional dyspepsia is a highly prevalent disorder that

56 There are also data to suggest that functional dyspepsia is caused by subtle manifestations

57 e economic burden of evaluating and treating functional dyspepsia is estimated to be at least $1 bill

58 gastric distention, an important feature of functional dyspepsia, is assessed by stepwise balloon di

59 The pathophysiology of functional dyspepsia may involve abnormal processing of

60 a specific disorder such as irritable bowel, functional dyspepsia, or abdominal migraine.

61 Twenty healthy controls and 62 patients with functional dyspepsia participated in a gastric barostat

62 c, acotiamide, reduces dyspepsia symptoms in functional dyspepsia patients.

63 A total of 86% met criteria for functional dyspepsia, primarily postprandial distress sy

64 Treatment of functional dyspepsia remains a challenge.

65 In adults with functional dyspepsia seen in a tertiary referral practic

66 n in Brazilian patients with peptic ulcer or functional dyspepsia showed no significant difference in

67 ), have been implicated in the generation of functional dyspepsia symptoms.

68 standard used to define the presence of true functional dyspepsia was epigastric pain, early satiety

69 Functional dyspepsia was found in 66% of the patients (2

70 Although the Rome III criteria for functional dyspepsia were defined 7 years ago, they have

71 owel syndrome, functional abdominal pain, or functional dyspepsia were randomized to 4 weeks of place

72 e Rome III criteria identified patients with functional dyspepsia with 60.7% sensitivity, 68.7% speci

73 he Rome II criteria identified patients with functional dyspepsia with 71.4% sensitivity, 55.6% speci